World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cance... (t Market under ticker symbol FLWS....)

(Date:5/12/2008)... MDX-1100 at Digestive Disease Week .../- Medarex, Inc.,(Nasdaq: ...hase 2 clinical,development program of MDX-1100, a...10 (also known as IP-10), in ulcerative colitis (U...otentially treat UC and RA by,suppressing the infl...

(Date:5/12/2008)...ewswire/ -- GlaxoSmithKline (GSK),in collaboratio...ding,academic breast cancer research network, and ...r Cooperative Group (SOLTI), today announced the s... the role of TYKERB(R) in the,treatment of early b.../or,Trastuzumab Treatment Optimization) will evalu...

(Date:5/9/2008)... in national effort probing for,answers, By Joe...st, Pennsylvania Game Commission, NOTE: Photos...from the,Game Commission,s website (http://www.pg..., HARRISBURG, Pa., May 7 /PRNewswire-USNewswire/...elf on a new frontier: it is working with several,...

(Date:5/9/2008)...wire/ -- Osteoarthritis is a,painful and potential...illion people in the United States. It is caused b...ovel investigational pain medication,tapentadol, a...cant relief,for patients with joint-disease pain, ...ewer gastrointestinal side effects than those trea...

Breaking Medicine Technology:Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis 2 Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis 3 Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis 4 TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 2 TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 3 TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 4 TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 5 TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 6 TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial 7 White Nose Syndrome: Is Pennsylvania Next? 2 White Nose Syndrome: Is Pennsylvania Next? 3 White Nose Syndrome: Is Pennsylvania Next? 4 White Nose Syndrome: Is Pennsylvania Next? 5 White Nose Syndrome: Is Pennsylvania Next? 6 Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 2 Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 3 Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 4 Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile 5 Members of Congress and Disability Rights Advocates Support the Restoration of the Americans with Disabilities Act and Welcome Back the Road To Freedo 6325 1 Members of Congress and Disability Rights Advocates Support the Restoration of the Americans with Disabilities Act and Welcome Back the Road To Freedo 6325 2 Members of Congress and Disability Rights Advocates Support the Restoration of the Americans with Disabilities Act and Welcome Back the Road To Freedo 6325 3 All Pets With Cancer in U S Provided Free Consultation 6323 1 All Pets With Cancer in U S Provided Free Consultation 6323 2 All Pets With Cancer in U S Provided Free Consultation 6323 3 All Pets With Cancer in U S Provided Free Consultation 6323 4 National Kidney Foundations 27th Annual Kidney Ball Featuring Entertainment by Patti LaBelle 6321 1 Lucian Leape Institute Announces First Roundtable 6319 1 Lucian Leape Institute Announces First Roundtable 6319 2 Lucian Leape Institute Announces First Roundtable 6319 3

[0] Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis [0] TYKERB(R) (Lapatinib) to be Investigated in Landmark Early Breast Cancer Trial [0] White Nose Syndrome: Is Pennsylvania Next?[0] Results of Phase 3 Study Show Tapentadol IR Relieves Acute Pain and Offers Favorable Gastrointestinal Tolerability Profile

...--Jul 9, 2007 - Pro-Pharmaceuticals,Inc. (Amex: P...ce(R)", today updated the progress of its Phase II...atic, unresectable,colorectal cancer patients who ...in, and its Phase II clinical trial for first-line...or both,indications may represent orphan drug stat...

..., 2007 - Late-breaking Phase III,clinical trial da...y on Thrombosis and Haemostasis (ISTH) Congress de...erior efficacy in the,prevention of venous thrombo...ment surgery in a head-to-head comparison with,eno... the RECORD3,(REgulation of Coagulation in major O...

Other Medicine Technology:Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 2 Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 3 Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 4 Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings 5 Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 2 Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 3 Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 4 Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery 5

Pro-Pharmaceuticals Updates Progress of Clinical Trials &,Davanat 505 (b)(2) Filings Phase III Trial Results Show Superiority of Rivaroxaban over,Enoxaparin for the Prevention of Venous Thromboembolism in Patients,Undergoing Knee Replacement Surgery

(Date:5/13/2008)...-- United American Healthcare,Corporation (Nasdaq:...nagement services to a full-service managed care o...l results for its third fiscal quarter,ended March... million for the third fiscal,quarter ended March ...or,the third quarter of the prior fiscal year. The...

(Date:5/13/2008)...re-FirstCall/ -- IRIDEX,Corporation (Nasdaq: IRIX...quarter of 2008 ended March 29, 2008., Revenue fo...8.7%,decrease from the $12.6 million reported for ...was $0.9 million or $0.10 per diluted share for th...f $4.9 million or $0.61 per,diluted share in the f...

(Date:5/13/2008)... Ongoing; Company Prepares for, Potential 2008 Lau...llion in Quarter, G...iddleBrook,Pharmaceuticals, Inc. (Nasdaq: MBRK ),...d commercializing novel anti-infective products, t...or the quarter ended March 31,2008., MiddleBrook...

(Date:5/13/2008)... the poor from improving, study finds , ,...of care at hospitals that treat poor and underserv... lagging well behind hospitals that do not serve t...tals, which rely on state and federal funding from... to improve the quality of care at the same rate t...

[0] United American Healthcare Corporation Announces Fiscal 2008 Third Quarter Results [0] IRIDEX Reports First Quarter 2008 Financial Results [0] MiddleBrook Pharmaceuticals Reports First Quarter 2008 Results [0] Quality Lags at Safety-Net Hospitals

...acteria known as E. coli 0157:H7 causes some of th...en and adults. Infections with this organism are o...udy shows using antibiotics to treat children with...he risk of developing a potentially deadly liver d...

...ysfunction is associated with loss of libido, low ...men who have attained their menopause or whose ova...Dehydroepiandosterone(DHEA), may serve as an effec...n, according to a study released at the 96th annua...

...cal Association (IMA) is embarking on an exercise ...country, according to Dr. Sanjiv Malik, Honorary S...so entered into an alliance with ORGMARG to create...ners in the country, be it allopathy or homeopathy...

...isclosure, Dr. Murali Ankem, a resident in Urology... University of New Jersey Medical and Dental Schoo...sed in prostate cancer treatment can migrate to ot...s. In a procedure called Brachytherapy, tiny metal...

Other Medicine News:

Antibiotic induces liver damage in children with E.COLI infections.New dimension in the treatment of female sexual dysfunction IMA to create database on physicians Radioactive Seeds used in Prostate Cancer treatment can migrate with the body

...Plate at Once , To increase efficiency and throug...t can adapt to the narrow well spacing. Thats exac...or., Available with Impact or Impact2 software (s...ly designed to allow you to transfer an entire col...

EnTrust family of ICDs provides a suite of features for total AT/AF co-morbidity management, including diagnostics to detect when your patient develops AT/AF, and both termination and intervention th

Designed to create a near bloodless field and provide myocardial protection during target vessel anastomosis. Its unique internal coil and tapered tip have been designed to allow easy, atraumatic ins

Medicine Products:

Impact2 16-Channel Electronic Pipettor, 2-125L Impact 16-Channel Electronic Pipettor, 1.0-30L EnTrust Dual Chamber ICD Axius™ Coronary Shunt

World Renowned Cancer Centers Implore Americans to Donate $1 to Make Change and Accelerate Cance...(t Market under ticker symbol FLWS....),Health